Roche Holding (ROG.SW) Market Capitalization, Earnings, Price, Holders
Roche Holding
Symbol: ROG.SW Rank: #37 Price: $282.59(0.32017%)

Market Cap: $227.8B($729.5M) Industry: Drug Manufacturers General Sector: Healthcare Country: Switzerland Insiders: n/a Institutions: 40.344%
Roche Holding AG Technicals

52 Week High: $405.04

52 Week Low: $269.96

50 Day MA: $287.53

200 Day MA: $311.33

52 Week Trading Range

9%

Low: $269.96

High: $405.04

Daily Trading Range

98%

Low: $279.98

High: $282.64

Market capitalization history for Roche Holding (ROG.SW) in USD

As of November 2023, Roche Holding (ROG.SW) has a market cap of $227.8 billion. Our data points out that ROG.SW is ranked #37 in the world. A company's market capitalization is the present value of all of its outstanding shares, and it is commonly used to give a sense of how much the stock of a company would be worth at today's exchange rates. ROG.SW's market cap is 0.320169% up from the last trading day.

ROG.SW Statistics

Market Cap
$227,852,316,666
Revenue TTM
$66,564,300,000
Gross Profit TTM
$47,927,600,000
Operating Margin TTM
31.9%
EBITDA
$24,741,400,000
Shares Outstanding
692,490,000
Shares Float
673,325,699
Trading Volume
770,722
P/E Ratio
15.3074
PEG Ratio
3.4625
Revenue Per Share
83.032
Dividend Per Share
9.5
Dividend Yield
0.028
Exchange
SW
Currency
CHF
Quote Type
EQUITY

Latest News

Roche Holding (ROG.SW) Shares Stats
Roche Holding (ROG.SW) Valuation
Trailing P/E $15.34
Forward P/E $14.23
Price Sales TTM $3.73
Price Book MRQ $9.65
Enterprise Value $271,344,213,317
Enterprise Value Revenue $4.21
Enterprise Value Ebitda $11.76
Roche Holding AG Details

Address: Konzern Hauptsitz

City: Basel

Zip: 4070

Phone: 41 61 688 11 11

Website: https://www.roche.com

IPO Date: n/a

CEO: Dr. Severin Schwan Ph.D.

Employees: 100,920

What is ROG.SW about?

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.